Syntal Capital Partners, LLC - Valeant Pharmaceuticals ownership

Quarter-by-quarter ownership
Syntal Capital Partners, LLC ownership history of Valeant Pharmaceuticals
ValueSharesWeighting
Q3 2019$380,0009,5000.10%
Other shareholders

There were no reported owners of Valeant Pharmaceuticals in Q4 2019.

NameSharesValueWeighting ↓
View complete list of Valeant Pharmaceuticals shareholders